glp 1 dementia prevention Can GLP-1 Medications Like Ozempic or Mounjaro Help Prevent Dementia? - The Health & Aging Brain Study GLPs Reduce Dementia Risk #Shorts

Patients who might be considered for GLP-1 therapy (within licensed indications) and who may experience secondary benefits for binge eating behaviours include: Individuals with binge eating disorder and type 2 diabetes , where GLP-1 agonists address the primary diabetes indication whilst potentially helping with eating patterns Those with BED and obesity who meet NHS eligibility criteria for weight management medications (as defined by NICE TA875 for semaglutide or TA664 for liraglutide, which are narrower than the marketing authorisation) Patients who have not responded adequately to psychological interventions such as cognitive behavioural therapy (CBT) and who have concurrent metabolic conditions Those experiencing significant food cravings and loss-of-control eating as part of their weight management challenges However, important cautions and considerations apply

That part is honestly valuable, especially here in Indian cities where tap water quality is inconsistent

Reinforce that approved uses come with known benefitrisk profiles based on robust trials

7 July 2016